MDT

88.65

+1.69%↑

VEEV

282.96

-1.55%↓

120.24

+1.92%↑

WBA

11.49

+0.26%↑

HQY

102.79

-1.67%↓

MDT

88.65

+1.69%↑

VEEV

282.96

-1.55%↓

120.24

+1.92%↑

WBA

11.49

+0.26%↑

HQY

102.79

-1.67%↓

MDT

88.65

+1.69%↑

VEEV

282.96

-1.55%↓

120.24

+1.92%↑

WBA

11.49

+0.26%↑

HQY

102.79

-1.67%↓

MDT

88.65

+1.69%↑

VEEV

282.96

-1.55%↓

120.24

+1.92%↑

WBA

11.49

+0.26%↑

HQY

102.79

-1.67%↓

MDT

88.65

+1.69%↑

VEEV

282.96

-1.55%↓

120.24

+1.92%↑

WBA

11.49

+0.26%↑

HQY

102.79

-1.67%↓

Home・Aktien・Lyell Immunopharma Inc

Lyell Immunopharma Inc

Geschlossen

9.31 6.77

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

8.66

Max

9.5

Schlüsselkennzahlen
By Trading Economics
Einkommen	140M -52M
Verkäufe	-4K 7K
EPS	-3.6
Gewinnspanne	-745,642.857
Angestellte	300
EBITDA	3.7M -54M

Empfehlungen
By TipRanks
Empfehlungen	Sell
12-Monats-Prognose	+24.43% upside

Dividenden
By Dow Jones
Nächstes Ergebnis	5. Aug. 2025

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	133M
Vorheriger Eröffnungskurs	2.54
Vorheriger Schlusskurs	9.31

Technischer Score

By Trading Central

Vertrauen

Strong Bearish Evidence

0.4217 / 0.4691 Unterstützung & Widerstand

Lyell Immunopharma Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

1. Juli 2025, 23:09 UTC

Ergebnisse

Constellation Brands 1Q Profit, Sales Decline Amid Softer Consumer Demand -- Update

1. Juli 2025, 19:16 UTC

Akquisitionen, Fusionen, Übernahmen

Sabadell Seeks Shareholder Approval of Nearly $4 Billion Sale of U.K. Unit to Santander

1. Juli 2025, 23:47 UTC

Market Talk

Nikkei May Fall Amid U.S. Tariff Uncertainty -- Market Talk

1. Juli 2025, 23:41 UTC

Market Talk

Gold Steady, Underpinned by U.S. Fiscal-Deficit Concerns -- Market Talk

1. Juli 2025, 22:23 UTC

Akquisitionen, Fusionen, Übernahmen

James Hardie: Deal Represents Implied Value of $8.4 Billion

1. Juli 2025, 22:23 UTC

Akquisitionen, Fusionen, Übernahmen

James Hardie: Cash and Stock Deal Implies $54.18 Per AZEK Share

1. Juli 2025, 22:21 UTC

Akquisitionen, Fusionen, Übernahmen

James Hardie Completes Acquisition of AZEK

1. Juli 2025, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

1. Juli 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

1. Juli 2025, 20:24 UTC

Ergebnisse

Constellation Brands Earnings Miss as Consumers Cool on Alcohol -- Barrons.com

1. Juli 2025, 19:55 UTC

Market Talk

Oil Futures Resume Cautious Rally -- Market Talk

1. Juli 2025, 19:27 UTC

Market Talk

U.S. Natural Gas Futures Lose More Ground -- Market Talk

1. Juli 2025, 19:12 UTC

Market Talk

Dollar Little Changed as Tax-And-Spending Bill Advances -- Market Talk

1. Juli 2025, 19:01 UTC

Akquisitionen, Fusionen, Übernahmen

Sabadell Seeks Shareholder Approval of Nearly $4B Sale of U.K. Unit to Santander

1. Juli 2025, 18:41 UTC

Akquisitionen, Fusionen, Übernahmen

How DexCom, Insulet, and Amedisys Might Be Affected by Medicare Cuts -- Barrons.com

1. Juli 2025, 18:33 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

1. Juli 2025, 18:33 UTC

Market Talk

Gold Gains as Investors Look Ahead on Budget Bill -- Market Talk

1. Juli 2025, 18:32 UTC

Market Talk

Mexico Manufacturing PMIs Remain Weak in June -- Market Talk

1. Juli 2025, 18:22 UTC

Market Talk

Remittances to Mexico Down in May -- Market Talk

1. Juli 2025, 17:45 UTC

Market Talk

Seasonal Demand Supports Further Oil Gains -- Market Talk

1. Juli 2025, 17:01 UTC

Akquisitionen, Fusionen, Übernahmen

Danone Completed Acquisition of Majority Stake in Kate Farms

1. Juli 2025, 16:55 UTC

Ergebnisse

10 European Dividend Stocks That Could Beat Their U.S. Counterparts -- Barrons.com

1. Juli 2025, 16:27 UTC

Market Talk

Trade Concerns Ease in Bank of Mexico Survey -- Market Talk

1. Juli 2025, 16:25 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Home Depot's GMS Buy Unlocks New Vertical Adjacent to SRS -- Market Talk

1. Juli 2025, 16:20 UTC

Market Talk

Health Care Roundup: Market Talk

1. Juli 2025, 15:48 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Home Depot's Offer for GMS Unlikely to Be Beat -- Market Talk

1. Juli 2025, 15:46 UTC

Market Talk

Global Equities Roundup: Market Talk

1. Juli 2025, 15:46 UTC

Market Talk

Amazon Seen With Improved Logistics Ahead of Longer Prime Day -- Market Talk

1. Juli 2025, 14:54 UTC

Market Talk

Thales Expected to Stick to This Year's Sales Guidance -- Market Talk

1. Juli 2025, 14:49 UTC

Market Talk

Platinum Prices Extend Rally on China Demand, Supply Worries -- Market Talk

Peer-Vergleich

Kursveränderung

Lyell Immunopharma Inc Prognose

Kursziel

By TipRanks

24.43% Vorteil

12-Monats-Prognose

Durchschnitt 11 USD 24.43%

Hoch 12 USD

Tief 10 USD

Basierend auf 3 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Lyell Immunopharma Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Sell

3 ratings

Buy

Halten

Sell

Basierend auf 3 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Lyell Immunopharma Inc – Dist abgegeben haben.

Technischer Score

By Trading Central

0.4217 / 0.4691Unterstützung & Widerstand

Recent bearish events outweigh bullish events.

There is one bearish event.

There are no events.

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Andere Aktien aus dem Sektor

MDT

Medtronic PLC

88.65

↑ +1.69%

VEEV

Veeva Systems Inc

282.96

↓-1.55%

Agilent Technologies Inc

120.24

↑ +1.92%

WBA

Walgreens Boots Alliance Inc

11.49

↑ +0.26%

HQY

HealthEquity Inc

102.79

↓-1.67%

Lyell Immunopharma Inc

Übersicht

Veränderung der Aktienkurses

Schlüsselkennzahlen

Empfehlungen

Dividenden

Marktstatistiken

Technischer Score

Lyell Immunopharma Inc Chart

Ähnliche Nachrichten

Peer-Vergleich

Lyell Immunopharma Inc Prognose

Kursziel

Rating-Konsens

Technischer Score

Finanzen

Andere Aktien aus dem Sektor